GGrantIndex
← Leaderboards

Zheng Gang Zhang

Henry Ford Health System

$14,094,277
Attributed
$14,094,277
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.5M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$14,594,277 · 15

By mechanism

R01$10,486,994 · 6
P01$2,745,640 · 2
S10$1,000,000 · 6
P50$361,643 · 1

Top collaborators

No co-investigators on record.

Most similar at Henry Ford Health System

Same institution · by research overlap

Others in their field

Top investigators on “Stroke

Research focus

StrokeMolecularMediatingLeadAdultEndothelial CellsGenesThrombosisNeuronsCellsTissuesSignal TransductionProteinsAftercareCerebrumRattusKnock-OutBaseNeurological OutcomeMicrornasAlteplaseLipidsAcuteAttenuated

Grant awards (48)

Exosome therapy for acute stroke with large artery occlusion$395,252
R01 · FY2023 · NS · contact PI
Exosome therapy for acute stroke with large artery occlusion$395,252
R01 · FY2022 · NS · contact PI
Exosomes and platinum-induced peripheral neuropathy$351,373
R01 · FY2022 · CA · contact PI
Exosome therapy for acute stroke with large artery occlusion$395,252
R01 · FY2021 · NS · contact PI
Exosomes and platinum-induced peripheral neuropathy$358,545
R01 · FY2021 · CA · contact PI
Exosome therapy for acute stroke with large artery occlusion$395,252
R01 · FY2020 · NS · contact PI
Exosomes and platinum-induced peripheral neuropathy$358,545
R01 · FY2020 · CA · contact PI
Exosome therapy for acute stroke with large artery occlusion$395,252
R01 · FY2019 · NS · contact PI
Exosomes and platinum-induced peripheral neuropathy$347,788
R01 · FY2019 · CA · contact PI
Exosomes and platinum-induced peripheral neuropathy$358,545
R01 · FY2018 · CA · contact PI
Ac-SDKP for Treatment of Acute Stroke$324,844
R01 · FY2017 · NS · contact PI
Ac-SDKP for Treatment of Acute Stroke$324,844
R01 · FY2016 · NS · contact PI
Ac-SDKP for Treatment of Acute Stroke$324,844
R01 · FY2015 · NS · contact PI
MicroRNAs and neurogenesis after stroke$320,469
R01 · FY2015 · NS · contact PI
Ac-SDKP for Treatment of Acute Stroke$321,596
R01 · FY2014 · NS · contact PI
MicroRNAs and neurogenesis after stroke$317,263
R01 · FY2014 · NS · contact PI
Ac-SDKP for Treatment of Acute Stroke$324,844
R01 · FY2013 · NS · contact PI
MicroRNAs and neurogenesis after stroke$309,253
R01 · FY2013 · NS · contact PI
MicroRNAs and neurogenesis after stroke$320,469
R01 · FY2012 · NS · contact PI
Basic Investigations in Brain Remodeling$391,223
P01 · FY2011 · NS · contact PI
MicroRNAs and neurogenesis after stroke$320,469
R01 · FY2011 · NS · contact PI
Basic Investigations in Brain Remodeling$391,224
P01 · FY2010 · NS · contact PI
Basic Investigations in Brain Remodeling$383,666
P01 · FY2009 · NS · contact PI
Treatment of Acute Embolic Stroke with Statins and rt-PA$351,988
R01 · FY2009 · HL · contact PI
Basic Investigations in Brain Remodeling$372,491
P01 · FY2008 · NS · contact PI
Treatment of Acute Embolic Stroke with Statins and rt-PA$351,988
R01 · FY2008 · HL · contact PI
Basic Investigations in Brain Remodeling$361,643
P50 · FY2007 · NS · contact PI
Treatment of Acute Embolic Stroke with Statins and rt-PA$351,988
R01 · FY2007 · HL · contact PI
Analysis of Marrow Stromal Cell Interaction with Tissue$241,761
P01 · FY2007 · NS · contact PI
Treatment of Acute Embolic Stroke with Statins and rt-PA$362,500
R01 · FY2006 · HL · contact PI
VEGF and Angiopoietin 1 Therapy for Stroke$265,315
R01 · FY2006 · NS · contact PI
Analysis of Marrow Stromal Cell Interaction with Tissue$249,085
P01 · FY2006 · NS · contact PI
Radiance 2100 AG-2Q Confocal Multiphoton System$500,000
S10 · FY2005 · RR
VEGF and Angiopoietin 1 Therapy for Stroke$271,700
R01 · FY2005 · NS
Analysis of Marrow Stromal Cell Interaction with Tissue$240,314
P01 · FY2005 · NS
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: STROKE, BRAIN TUMOR$165,000
S10 · FY2005 · RR
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: HYPERTENSION$95,000
S10 · FY2005 · RR
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: ADULT ANIMAL STEM CELLS, PLASTICITY, TBI$95,000
S10 · FY2005 · RR
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: NEUROSCIENCE, BLOOD STUDIES$95,000
S10 · FY2005 · RR
RADIANCE 2100 AG-2Q CONFOCAL SYSTEM: GLIOMA RESEARCH$50,000
S10 · FY2005 · RR
VEGF and Angiopoietin 1 Therapy for Stroke$271,700
R01 · FY2004 · NS
Microvascular Thrombosis After Embolic Stroke$257,041
R01 · FY2004 · HL
Analysis of Marrow Stromal Cell Interaction with Tissue$236,925
P01 · FY2004 · NS
VEGF and Angiopoietin 1 Therapy for Stroke$271,700
R01 · FY2003 · NS
Microvascular Thrombosis After Embolic Stroke$257,041
R01 · FY2003 · HL
Analysis of Marrow Stromal Cell Interaction with Tissue$238,951
P01 · FY2003 · NS
Microvascular Thrombosis After Embolic Stroke$257,041
R01 · FY2002 · HL
Microvascular Thrombosis After Embolic Stroke$257,041
R01 · FY2001 · HL